1-8 of 8
Elisa Roldan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Donor Chimerism Monitorization for Relapse Prediction in Ex-Vivo CD34-Selected Allogenic Hematopoietic Stem Cell Transplant

Sergi Camarillas, Gilda Coralia Cetina Castro, Alba Puyuelo, Elisa Roldan, Víctor Navarro Garces, Lorenzo Carita, Ana Perez Gonzalez, Maria Sola, Maria Laura Fox, Félix López-Cadenas, Pilar Verlarde, Guillermo Orti, Antonio Garcia, Anna Martín Carrizosa, Marina Serra, Olga Salamero, David Valcarcel
Journal: Blood
Blood (2024) 144 (Supplement 1): 2129.
https://doi.org/10.1182/blood-2024-208115
Published: 2024
Journal Articles

Long-Term Outcomes and Late Complications of Allogeneic Stem Cell Transplant with CD34+ Positive Selection in Adults with Acute Leukaemia and Myelodysplastic Syndrome: A Single-Centre Study

Elisa Roldan, Alba Puyuelo, Sergi Camarillas, Olga Salamero, Ana Perez Gonzalez, Maria Laura Fox, Felix Lopez, Maria Sola, Pere Barba, Guillermo Orti, David Valcarcel
Journal: Blood
Blood (2024) 144 (Supplement 1): 3545.
https://doi.org/10.1182/blood-2024-205956
Published: 2024
Journal Articles

Viral-Specific T Cell Therapy for Cytomegalovirus Infection after Stem Cell Transplantation and Generation of a Third-Party T-Cell Donor Registry

Pere Barba, Elisa Roldan, María Suárez-Lledó, Juan Montoro Gomez, Santiago Perez-Hoyos, Alberto Mussetti, Christelle Ferra, Ruth Coll, Luciano Rodriguez, Julia Marsal, Rodrigo Martino, Julio Castaño, Marga Codinach, Francesc Bosch, Ramon Gimeno, David Valcarcel, Francesc Rudilla, Sergio Querol
Journal: Blood
Blood (2022) 140 (Supplement 1): 10309–10310.
https://doi.org/10.1182/blood-2022-165943
Published: 2022
Journal Articles

Acute Myeloid Leukemia with Myelodisplasia-Related Changes (AML-MRC) Defined Only By Morphological Findings May Not Represent a Poor Prognosis AML

Ana Pérez, MD, Olga Salamero, MD, Helena Pomares, MD PhD, Maria Julia Montoro, MD, Montserrat Arnan Sangerman, MD PhD, Laura Gallur, MD, María Laura Fox, MD, Elisa Roldan, MD, Antonieta Molero, MD, Guillermo Ortí, MD, Mayda Navarrete, MD, Esther Alonso, MD, Bárbara Tazón, PhD, M Moraima Jimenez, MD, Margarita Ortega, PhD, Adoración Blanco, PhD, Gael Roue, PhD, Pere Barba, MD PhD, Silvia Saumell, MD PhD, David Valcárcel, MD PhD, Francesc Bosch, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2612.
https://doi.org/10.1182/blood-2019-129153
Published: 2019
Journal Articles

Graft-Versus-Host Disease (GVHD) Prophylaxis with Post-Transplant Cyclophosphamide (PTCY) Induces a More Tolerant Immune Response after Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients Previously Exposed to Nivolumab

Juan C Nieto, PhD, Elisa Roldan, MD, Isabel Jiménez, MSc, Laura Fox, Júlia Carabia, PhD, Guillermo Orti, Lluis Puigdefàbregas, Laura Gallur, Gloria Iacoboni, MD, Priyanka Raheja, Ana Perez, Olga Salamero, MD, Carlos Palacio, David Valcarcel, MD, Marta Crespo, PhD, Francesc Bosch, MD, Pere Barba, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3402.
https://doi.org/10.1182/blood-2018-99-114887
Published: 2018
Journal Articles

Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of a Multicenter Study from the Grupo Español De Trasplante Hematopoyético (GETH)

Leyre Bento, MD, Jose Maria Bastida, MDPhD, Irene García-Cadenas, Estefania García-Torres, MD, Daniel Rivera, MD, Anna Bosch, MD, Carlos de Miguel, MD, María Esther Martínez-Muñoz, MD, Francesc Fernández-Avilés, MD, Elisa Roldan, MD, Anabelle Chinea, MD, Lucrecia Yáñez, MD PhD, Teresa Zudaire, MD, Carlos Pinho-Vaz, MD, Ildefonso Espigado, MD PhD, Javier Lopez Jimenez, MD PhD, David Valcárcel, MD, Rafael F Duarte, MDPhDFRCP, Rafael Cabrera, MD PhD, Antonio Gutiérrez, MD PhD, Carlos Solano, MD PhD, Antonia Sampol, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 200.
https://doi.org/10.1182/blood-2018-200
Published: 2018
Journal Articles

Clinical Progression of Chronic Lymphocytic Leukemia (CLL) Is Characterized By a Progressive Increase of the Exhausted T-Cell Phenotype and Immunosuppression Induced By Leukemic Cells

Isabel Jiménez, MSc, Sabela Bobillo, MD, Pau Abrisqueta, MD PhD, Bárbara Tazón, PhD, Carles Palacio, MD, Juan C Nieto, PhD, Júlia Carabia, MSc, Maria Jose Terol, MD PhD, Jose Garcia-Marco, MD PhD, Joan Boix, BSc, Magdalena Munuera, BSc, Lluis Puigdefàbregas, Elisa Roldán, Marta Crespo, PhD, Francesc Bosch
Journal: Blood
Blood (2017) 130 (Supplement 1): 1713.
https://doi.org/10.1182/blood.V130.Suppl_1.1713.1713
Published: 2017
Journal Articles

An IPSS-R Cutpoint of 3 Stratified Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML) Patients (pts) into Two Risk Groups

Julia Montoro, Helena Pomares, Brayan Merchan, Antonieta Molero, Silvia Saumell, Esther Alonso, Mónica Fernández, Laura Gallur, Javier Grau, Olga Salamero, Adoración Blanco, Anna Varela, Elisa Roldán, Anna Sureda, Francesc Bosch, Montserrat Arnan Sangerman, David Valcarcel
Journal: Blood
Blood (2017) 130 (Supplement 1): 5306.
https://doi.org/10.1182/blood.V130.Suppl_1.5306.5306
Published: 2017